Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.
Luis M Pérez-BelmonteJosé P Miramontes-GonzálezJulio Osuna-SánchezJosé P LaraRicardo Gómez-HuelgasPublished in: Journal of the American Geriatrics Society (2022)